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Background
• Hemosuccus pancreaticus (HP) is a rare cause of upper gastrointestinal bleeding (UGIB) defined as bleeding from the ampulla of Vater through the main pancreatic duct. First described in 1970 by Dr. Sandblom and characterized by GIB causing anemia1 that can easily be overlooked, originating from a splenic artery aneurysm. Aneurysms and pseudoaneurysms (PA) are not the only causes of HP (Table 1 ).
• Bleeding is intermittent and repetitive and can be massive, but rare to cause hemodynamic instability.
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Diagnosis is difficult since endoscopy rarely reveals active hemorrhaging and CT imaging or angiography is needed to locate the source. Interventional radiology for embolization 5 or surgical consult with use of intraoperative pancreatoscopy 6 are needed based on the hemodynamic stability of the patient and ability to identify the source of hemorrhaging.
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Discussion
• HP is a rare disease with a male predominance (7:1). • Bleeding is intermittent due to clotting within the main pancreatic duct.
9
Bleeding from the major ampulla is seldom seen with EGD. Residual blood clots located near the ampulla 7 with lack of other bleeding sources can be indicative of the disease.
• If a nondiagnostic EGD, CT scan of the abdomen is the imaging modality of choice to identify pancreatic pathology 5 followed by angiography, gold standard for detecting PAs.
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• Coil embolization has a 79-100% success rate 10 and a mortality rate of 12-33%. • If hemodynamically unstable or embolization has failed, surgery is recommended. Common procedures include bipolar arterial ligation, direct intra-pseudocystic ligation with drainage 9 , pancreaticoduodenectomy or splenopancreatectomy.
5
• The incidence of HP may rise in the future as a result of increasing alcohol use, primarily in males 11 in the western countries, leading to more cases of pancreatitis.
Case Presentation
• A 35 year old male with complaints of progressive fatigue and generalized weakness over two weeks presents to an outside facility with a past medical history of occult gastrointestinal bleed, previous alcohol abuse and acute pancreatitis. He denied melena, hematochezia, hematemesis, nausea/vomiting, or chronic ibuprofen usage. Laboratory studies revealed a hemoglobin of 2.8 g/dL.
• Initial esophagogastroduodenoscopy (EGD) revealed an actively bleeding mass at the major papilla, a non-bleeding ulceration at the GE junction and absence of gastric and esophageal varices. Colonoscopy revealed no pathology.
• The patient developed epigastric tenderness and spiking fevers as high as 102 o F and elevated lipase level at 803 U/L upon presentation to our institution.
• Repeat EGD revealed a clean based ulcer in the distal esophagus and mild thickening of the duodenal sweep mucosa; no bleeding or mass at the ampulla. Duodenal biopsies revealed signs of chronic inflammation.
• A CT scan of the abdomen/pelvis revealed pancreatitis consistent with splenic artery pseudoaneurysm (image1), splenomegaly and a pancreatic head lesion (image 2).
• Interventional radiology performed an abdominal angiography identifying an 8mm splenic artery pseudoaneurysm from the proximal-mid splenic artery with no active bleeding. Coil embolization (image 3) and repeat imaging confirmed no residual pseudoaneurysm (image 4) and a new splenic infarct (image 5).
• Follow-up MRI showed an ill-defined area of decreased attenuation in the head of the pancreas, fatty infiltrates within the liver and splenic infarct.
Patient was afebrile with no abdominal pain, a stable hemoglobin and vaccinated for encapsulated bacteria at time of discharge.
Conclusion
HP is a rare cause of an UGIB that is difficult to diagnose with endoscopy alone and often requires additional imaging. It should be included in the differential for any male patient presenting with melena, generalized weakness and fatigue with a low hemoglobin with a history of pancreatitis that can not be explained by a more common cause. Treatment by embolization should be attempted prior to surgical interventions. The incidence of HP may rise with an increase in laparoscopic surgeries, the use of EUS-FNA and the continued trend of alcohol use inducing pancreatitis. Image. 1 -CT abdomen/pelvis with contrast revealing pseudoaneurysm (arrow) located in the proximal-mid splenic artery and splenomegaly (not fully appreciated in this cut).
Image 2 -CT of abdomen/pelvis that visualizes the nonspecific pancreatic mass (arrow) located in the head of the pancreas.
Image 3 -Angiography of the splenic artery and the pseudoaneurysm (arrow)prior to coil embolization.
Image 4 -Angiography status post coil embolization indicating no filling of the splenic artery pseudoaneurysm after coil placement.
Image 5 -CT of abdomen/pelvis status post coil embolization with several areas of infarction within the spleen (arrow). Coils within the splenic artery are visualized.
